About Sollis Therapeutics

Sollis Therapeutics is a clinical-stage specialty pharmaceutical company developing novel non-steroid, non-opioid analgesics. Sollis’ first product is an extended-release combination analgesic and anti-inflammatory drug designed for local delivery for the treatment of sciatica and other neuropathic pain syndromes. The company was founded in 2017 and is headquartered in Columbus, Ohio.

Company Highlights
Year Founded

2017

icon-altEmployees

23

Location (HQ)

USA

Since Last Funding

3 years 5 months

Monthly Website Visitors

1876.2M

icon-altTotal Investment Amt

$53M

Last Funding Round

Debt Financing

icon-altYoY Headcount Growth

-4.15%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Pharmaceutical

Biotechnology

Medical

Pharmaceuticals

Therapeutics

Pharmaceutical Manufacturing